Scientific Program

Conference Series Ltd invites all the participants across the globe to attend International Conference and Exhibition on Dual Diagnosis Chicago, Illinois, USA.

Submit your Abstract
or e-mail to

events@conferenceseries.com
dualdiagnosis@conferenceseries.net
dualdiagnosis@conferenceseries.com

Scientific Program Day 1
Scientific Program Day 2

Day 2 :

Keynote Forum

Francis Acquah

Chairman of the Board at Mental Health Foundation of Ghana, Australia

Keynote: Transforming Mental Health Services in Ghana: Blending traditional healing

Time : 09:00-09:40

Conference Series Dual Diagnosis 2016 International Conference Keynote Speaker Francis Acquah photo
Biography:

Francis Acquah Born in West Africa, Francis qualified as a Mental Health Nurse in the United Kingdom and is a Credentialed Mental Health Nurse accredited by the Australian College of Mental Health Nurses. He has over 25 years of experience across youth, adult, public and private health care in Australia and the United Kingdom and has undertaken a range of roles, including clinical, managerial and educational. He has also served as a Specialist Pharmaceutical advisor for a leading pharmaceutical company.

Abstract:

The West African country of Ghana is situated just north of the equator bordering the Atlantic Ocean. Ghana’s tropical beaches and picturesque countryside are starkly contrasted by the destitute and inhumane living environments of people living with mental health conditions who often find themselves subjected to archaic treatment regimes as articulated in the report “Like a Death Sentence”, Human Rights Watch (2012). rnThe MHFGH was formed as a direct result of this report and comprises mental health professionals and academics mainly based in the diaspora. It is a registered charity and contributes to government, community and private efforts to promote mental health and wellbeing, and reduce stigmatisation of mental illness in Ghana. rn

Keynote Forum

Andrzej Kiejna

Wroclaw Medical University, Poland

Keynote: Dual Diagnos- mental disorders associated with addiction (ICD-10 or DSM-5)

Time : 09:40-10.20

Conference Series Dual Diagnosis 2016 International Conference Keynote Speaker Andrzej Kiejna photo
Biography:

Chair of Department and Clinic of Psychiatry at Wroclaw Medical University, and head physician in charge at Lower Silesian Center for Mental Health (DCZP) and at Independent Public Clinical Hospital . • Consultant psychiatrist and epidemiologist. • Author of more than 350 articles in the field of psychopharmacology, social psychiatry. epidemiology and history of psychiatry.

Abstract:

According to the definition of dual diagnosis mental disorders associated with addiction should meet the ICD-10 or DSM-5.Literature data indicate that about 30-50% addicted to alcohol or other drugs have severe mental disorder, which is twice higher rate than the population do not use psychoactive substances. Similarly, among the major mental disorder, approximately 30% used alcohol and suffering from disorders associated with it. In Poland in the years 2010-11was carried out study of the prevalence of mental disorders in the general population in adults, according to the methodology of the World Mental Health Survey Initiative. Among the most common lifetime (LT) diagnostic categories were diagnosed with alcohol abuse, males 18.6% and females 3.3% and addiction respectively 4.1% and 0.4%. In contrast, substance addiction, 1.8% in men and 0.8% among women. Currently, we conduct a detailed analysis of the link between substance addiction and the presence of other diagnostic categories. On the other hand, when analyzing data from the Statistical Yearbook of the Institute of Psychiatry and Neurology in Warsaw we will notice a significant increase in admissions to stationary psychiatric institutions patients with dual diagnosis in the years 1997 - 2005 from the 3.2% to 7.6% in relation to all admission. However, this indicator stabilized in subsequent years, despite the relatively high percentage of addicts. In 2010, the largest group consisted of patients with a diagnostic category F20-29, while relatively infrequent comorbidity of anxiety and affective disorders.

Keynote Forum

Nachum Dafny

University of Texas Health Science Center, USA

Keynote: Where in the brain ritalin exerts its effects
Biography:

Nachum Dafny has received his MS and PhD degrees from Hadassah Medical School in Jerusalem in 1965 and 1969, respectively followed by post-docs at
Caltech, UCLA, and Columbia. He is currently a Professor of Neurobiology at the University of Texas Medical School at Houston.

Abstract:

Methylphenidate (MPD) is a readily prescribed drug for the treatment of attention defi cit hyperactivity disorder (ADHD)
and moreover it is used and abused by youths and young adults for its cognitive enhancing eff ects and recreation.
Repetitive MPD exposure leads to an augmented behavioral response referred to as behavioral sensitization, an experimental
marker for a drugs ability to elicit dependence. Th ere is evidence that dopamine (DA) and GABA are key players in the acute and
chronic MPD eff ect, however the exact roles of DA and GABA in the eff ects elicited by MPD are still debated. Psychostimulants
such as cocaine and amphetamine exert their eff ects on brain regions known as the motive or reward circuit. Since MPD has
functionally and structurally similar properties as amphetamine and cocaine, it is important to fi nd out whether MPD elicits
its eff ect on some of the motive circuit nuclei such as the nucleus accumbens (NAc), prefrontal cortex (PFC), caudate nucleus
(CN), and ventral tegmental area (VTA) and the role of DA and GABA in MPD eff ects. Th e study lasted for 12-21 consecutive
days. Seventeen groups of male SD rats were used to produce electrical and chemical lesions in the VTA, NAc, PFC, and CN,
and GABA, DA D1 and D2 antagonists were used. Data will show the role of the VTA, NAc, PFC, and CN and the eff ects of
DA and GABA on acute and chronic MPD action.

Keynote Forum

Charles W. Graham

Community College of Aurora, USA

Keynote: Emotion: arousal, behavior, and cognition - considerations in intensive outpatient program environment
Biography:

Charles W. Graham has completed his PsyD from The Chicago School of Professional Psychology and graduate work at The University of North Texas. He is the
Chief Operating Offi cer/Executive Director of CoreVision Network, a premier dual diagnosis treatment organization based in Colorado Springs, CO. He is one of
the leading professionals in the fi eld of recovery and co-occurring disorders. He was the Program Director at Sober Living by the Sea, one of the premier treatment
centers in America, for fi ve years, and for the past fi ve years he has been the Executive and Clinical Director at Behavioral Health Synergy where he has started
up numerous sober living homes, treatment centers, and counseling centers. He has been a speaker at state and national conferences on such topics as Domestic
Violence and Substance Abuse, and Co-Occurring Bipolar Disorder and Substance Abuse. He is currently an Adjunct Professor of Psychology at The Community
College of Aurora.

Abstract:

The necessity to better understand the complex world of emotion is evident is the process of screening, assessment, case
formulation, and treatment of patients with co-occurring disorders. Th is presentation will bring theory into the arena
of evidenced-based treatment to one of the most diffi cult populations. It explores the nature of emotion, the predominant
underlying theories, and the interaction between the autonomic nervous system, the physiology of emotion, and application
in diagnosis, assessment, treatment, and remediation. Th is presentation covers the foundation for, and process of controlling
emotions, some potentially damaging myths about emotions, and the key habits of emotionally resilient people. Th is study
takes emotion out of the theoretical labroatory and into the practical application of fostering emotional maturity and resilience
in the care and treatment of patients with co-occurring disorders.

  • Addictive disorders and clinical interventions

Chair

Andrzej Kiejna

Wroclaw Medical University, Poland

Co-Chair

Gafarov Valery

FSBI Institute of Internal and Preventive Medicine, Russia

Session Introduction

Andrzej Kiejna

Wroclaw Medical University, Poland

Title: Dual diagnosis - Whether it is in Poland underestimated clinical phenomenon
Speaker
Biography:

Chair of Department and Clinic of Psychiatry at Wroclaw Medical University, and head physician in charge at Lower Silesian Center for Mental Health (DCZP) and at Independent Public Clinical Hospital. Consultant psychiatrist and epidemiologist. Author of more than 350 articles in the field of psychopharmacology, social psychiatry. epidemiology and history of psychiatry.

Abstract:

According to the definition of dual diagnosis mental disorders associated with addiction should meet the ICD-10 or DSM-5.Literature data indicate that about 30-50% addicted to alcohol or other drugs have severe mental disorder, which is twice higher rate than the population do not use psychoactive substances. Similarly, among the major mental disorder, approximately 30% used alcohol and suffering from disorders associated with it. In Poland in the years 2010-11was carried out study of the prevalence of mental disorders in the general population in adults, according to the methodology of the World Mental Health Survey Initiative. Among the most common lifetime (LT) diagnostic categories were diagnosed with alcohol abuse, males 18.6% and females 3.3% and addiction respectively 4.1% and 0.4%. In contrast, substance addiction, 1.8% in men and 0.8% among women.

Mutamba Byamah

Butabika national referral mental hospital, Uganda

Title: Mental disorders and non-communicable diseases
Biography:

SMIs are associated with significant hidden NCD morbidity however, despite the indicative trends, the small samples of each SMI category did not allow for further investigation of associated socio-demographic and metabolic factors. A larger sample and longitudinal study design will enable further investigation of this complex relationship in this patient population.

Abstract:

Mental disorders and non-communicable diseases (NCDs) commonly occur together and relate to each other in a complex way. People with severe mental illness (SMI) are at risk of the metabolic syndrome irrespective of antipsychotic treatment and are also at increased risk of other comorbid physical disorders. Because of their mental state, patients with SMI have limited access to appropriate health care and/or are not routinely assessed for these ailments resulting into poorer health outcomes. The profile of NCDs in patients with SMI in the patient population at Butabika Mental Hospital in Uganda is not well understood hence this study.

Deanna L Mulvihill

RN PhD, TLI Foundation, USA

Title: Women, trauma and alcohol dependency: Connections and disconnections in alcohol treatment for women
Biography:

Deanna Mulvihill has her expertise in evaluation and passion in improving the health and wellbeing. Her open and contextual evaluation model based on
responsive constructivists creates new pathways for improving health care. She has built this model after years of experience in research, evaluation, teaching and
administration both in hospital and education institutions. The foundation is based on fourth generation evaluation (Guba & Lincoln, 1989) which is a methodology
that utilizes the previous generations of evaluation: measurement, description and judgment. It allows for value-pluralism. This approach is responsive to all
stakeholders and has a different way of focusing.

Abstract:

Statement of the Problem: Women who have experienced intimate partner violence (IPV) are at greater risk for physical and
mental health problems including posttraumatic stress disorder (PTSD) and alcohol dependency. On their own IPV, PTSD and
alcohol dependency result in signifi cant personal, social and economic cost and the impact of all three may compound these costs.
Researchers have reported that women with these experiences are more diffi cult to treat; many do not access treatment and those who
do, frequently do not stay because of diffi culty maintaining helping relationships. However, these women’s perspective has not been
previously studied. Th e purpose of this study is to describe the experience of seeking help for alcohol dependency by women with
PTSD and a history of IPV in the context in which it occurs.
Methodology & Th eoretical Orientation: An intersubjective ethnographic study using hermeneutic dialogue was utilized during
participant observation, in-depth interviews and focus groups. An ecological framework was utilized to focus on the interaction
between the counselors and the staff to understand this relationships and the context in which it occurs.
Findings: Th e women in this study were very active help seekers. Th ey encountered many gaps in continuity of care including
discharge because of relapse. Although the treatment center was a warm, healing and spiritual place, the women left the center
without treatment for their trauma needs and many without any referral to address these outstanding issues.
Conclusion & Signifi cance: Women with alcohol dependence and PTSD with a history of IPV want help however the health and
social services do not always recognize their calls for help or their symptoms of distress. Recommendations are made for treatment
centers to become trauma-informed that would help this recognition.

Sareen Hagopian

Sigmund Freud University Vienna, Austria

Title: The struggle of an addict on the way to autonomy
Biography:

Sareen Hagopian is a Clinical Psychologist and Psychotherapist. She worked in diverse settings including but not limited to addiction rehabilitation center, hospital,
clinic, dispensary, and school. In addition, she also worked with varied populations including individuals with dependence, physically ill patients, refugees, domestic
migrant workers, students, and handicapped (mental and physical).

Abstract:

The following intervention aims at exploring addiction from the perspective of Existential Analysis. Th e addict in recovery asks
him/herself fundamental questions about his existence, self, and meaning, ultimately revealing his lack of the feeling of life; as he
battles constantly between dependence and autonomy. Th is empirical study uses a mixed research method with a qualitative interview
and quantitative scales on addiction severity, interpersonal reactivity, existential functioning, and fundamental existential motivations
with a sample of adults in a short-term inpatient addiction rehabilitation program in Lebanon with multiple addictions. An overview
of the existential themes addictive patients are occupied with will be presented (e.g. what moves them, what are their suff erings, what
is their lack, what disturbs them, etc.) Th is is followed by other possible causes of addiction; in addition to identifi cation of possible
changes on an existential level that the addicts might show before and aft er the treatment. Finally, the intervention will conclude on
implications of the fi ndings of this study for treatment of addictive patients.

Helen Northcott

Choose a Lifestyle, Canada

Title: Mental health comes fi rst
Biography:

Helen Northcot has completed her MA from Andrews University in Berrien Springs, Michigan and PhD from Almeda University. She is the Director of Choose a
Lifestyle, which is her private practice for Psychotherapy, Addiction Counseling, Anger Management and Alcohol Education classes. She is a Registered Psychotherapist
with the new College of Registered Psychotherapists of Ontario. She is a Registered Practical Nurse and is registered with the College of Nurses of
Ontario. She is a Vegetarian Cooking Instructor and an Ordained Minister. She has published two books and written for newspapers in Canada and Indonesia.

Abstract:

Thinking erroneously can be dangerous to your health. Volunteers of the National Hope line Network have answered over
seven million calls with the highest percentage (60%) of calls being for those in mental health crisis. Health care systems
are challenged to do mental health promotion and prevention to lower costs. Screening for mental health and one’s ability to
learn could provide the needed information to be proactive towards faster healing times. Th e ability to make good choices and
to reason from cause to eff ect is important for a healthy mind. We are what we think and what we eat. Dietary intake needs to
be adequate to make healthy neurotransmitters so messages from our central nervous system are sent and received properly.
Th e best therapeutic outcomes result when the brain’s pleasure centre, addictions, self harm and dual diagnosis is thoroughly
understood. Research has established through brain imaging we are spiritual and have the capacity to have a relationship
with God. Many are lacking a positive experience with God resulting in being spiritually sick. Complex human beings need
a holistic diagnosis to become well. Th e use of cognitive behavioral therapy and forgiveness therapy can bring about mental,
emotional, physical and spiritual healing

  • Drug Addiction

Session Introduction

Gafarov Valery

FSBI Institute of Internal and Preventive Medicine, Russia

Title: Gender differences in risk of MI and stroke in population with high levels of personal anxiety
Biography:

Mickael Naassila has completed his PhD in Neurosciences in 1998 from Rouen University and postdoctoral studies from Kansas University Pharmacy School Dept Pharmacol & Toxicol. He is the director of Research Group on Alcohol & Pharmacodependecences (GRAP – INSERM Eri 24). He has published more than 50 papers in the addiction field and is the President of the Society française d’alcoologie

Abstract:

Schizophrenia is a mental disorder characterized by a series of positive, negative or cognitive symptoms but with also the particularity of exhibiting high rate of comorbid use of drugs of abuse. While more than 80% of schizophrenics are smokers, the second drug the most consumed is alcohol with dramatic consequences on frequency and intensity of psychotic episodes and on life expectancy. Here we investigated the impact of light alcohol intake during adolescence on the subsequent occurrence of alcohol addiction-like behavior in neonatal ventral hippocampal lesion (NVHL) rats, a neurodevelopmental model of schizophrenia. Our findings demonstrated an increased liability to addictive behaviors in adult neonatal ventral hippocampal lesioned (NVHL) rats after voluntary alcohol intake during adolescence. NVHL rats displayed several signs of alcohol use disorder such as a loss of control over alcohol intake and high motivation to consume alcohol, associated with a higher resistance to extinction.

Diane Mintz

Sacramento National Alliance on Mental Illness, USA

Title: The impact of hearing stories of recovery from dual diagnosis
Biography:

Diane Mintz is an author, speaker, business owner, and mental health advocate. She serves on the board of the Sacramento National Alliance on Mental Illness. In her book and presentations, Diane reaches a diverse audience and gives an intimate insight into what it is like to battle and live successfully with a dual diagnosis. She presents at Crisis Intervention Trainings for law enforcement; to students, health professionals, church members, and families who want to know how to help their loved one. Diane’s mission is to give a new perspective of mental illness and addiction; a perspective that inspires society to support the afflicted and give them hope for recovery.

Abstract:

The human psyche can’t be reduced to textbooks or manuals. This reality adds to the incredible challenge for mental health professionals and addiction specialists to provide treatment from an occasional snapshot of their client. The fact that the general public is ignorant about dual diagnosis further compounds the problem, especially considering media’s continual influence on society’s bias when they focus on tragic events and provide misinformation. This ignorance perpetuates the stigma that keeps those afflicted with mental illness or addiction from getting well. The stigma dissipates when those with long-term recovery share their experience. The real-life perspective provides unique, valuable insights that only people with lived experience can provide. The catch twenty-two is that stigma prevents people from disclosing their lived experience. When the silent successful are willing and encouraged to tell their stories of recovery to the public in schools, churches, and various organizations, the impact is profound. The public, including those who offer treatment, get more exposure to people who are managing their illnesses and their lives well. Viewing dual diagnosis through the lens of those who have struggled will foster a paradigm shift of society’s view of mental illness and the disease of addiction, making recovery possible for those paralyzed by stigma. Without the cloak of shame, those struggling with a dual diagnosis can get support and make more progress with recovery. Without the barrier of stigma, more people would seek early treatment, resulting in a widespread improvement in a myriad of mental and physical illnesses.

Patricia Allen

Psychiatric Mental Health Nurse Practitioner, USA

Title: Application of pharmacogenetics testing with Co-Occurring Clients
Biography:

Patricia Allen is a Psychiatric Mental Health Nurse Practitioner and Executive Director of Nursing Services for Summit Behavioral Health. Summit provides addiction treatment services in Pennsylvania, New Jersey and Massachusetts. Pat is an Assistant Professor of Nursing and tenured faculty at Montgomery County Community College in Blue Bell, Pennsylvania. Pat is a DNP candidate at West Chester University in West Chester, Pennsylvania. Pat presented at the Cape Cod Symposium on Addictive Disorders and the Annual Conference of the American Psychiatric Nurse’s Association on topics related to pharmacogenetics and medication-assisted treatment for those with co-occurring disorders. She presented at the NEI Psychopharmacology Congress. Pat has discussed these topics in media opportunities.

Abstract:

More than 65% of those with substance use disorders also suffer from a mood or anxiety disorder. For the past decade pharmacogenetics has emerged as a promising clinical tool for the treatment of those with co-occurring disorders. This testing enables individualized treatment and offers the client and practitioner valuable information that can positively impact the course of treatment. Many of our clients come to us with unresolved or worsening symptoms, a history of treatment non-compliance, or premature discontinuation of prescribed medications due to the medication not working or intolerable side effects. Genetic testing guides the prescriber, individualizes care, educates the client, and facilitates a clinical partnership that empowers the client and supports recovery. With the advances in medication assisted treatment for addictions, genetics testing can helps us work with our patients to design the most successful recovery program. When patients have appropriate treatment from the beginning, they are more likely to remain in treatment and recovery. Current use of genetic testing is helping us to achieve retention rates greater than 90% in our treatment programs. Case studies which demonstrate the clinical value of genetic testing, its impact on clinical outcomes for clients with co-occurring disorders, and reduces the stigma that is a barrier to treatment.

Matteo perve

Medicitalia, Switzerland

Title: Misuse of pregabalin: case series and literature review
Biography:

Preve M is from Psychiatric Clinic, Sociopsychiatric Organization, Mendrisio, Switzerland

Abstract:

Pregabalin (Lyrica) is widely used in neurology, psychiatry and primary healthcare. Pregabalin has shown greater potency than gabapentin in preclinical models of epilepsy, pain and anxiety, and pregabalin may have potential in the treatment of some aspects of cocaine addiction. The purpose of this report is to review the clinical evidence for the potential of abuse and misuse of pregabalin. We propouse ten different cases and literature review. Method Ten inpatients with misuse of pregabalin were assessed with: the SCID-P, Anamnestic Folio to qualify all the possible clinical correlates linked to drugs abuse, Hamilton Anxiety Scale (HAM-A) and Drug Abuse Screening Test (DAST). All patient received a complete internistical examination, blood test exams and as well as a urine drugs screening. We conducted a systematic review of the literature.

Gary Thompson

University of Toronto, Canada

Title: Development and Implementation of an Opioid Overdose Prevention and Response Program
Biography:

well known to increase morbidity and mortality. Results in increased health care costs, due to brain damage etc. A rise in drug use, abuse and a loss of trust in the medical profession, harm reduction & addictions counsellors. Be assured Ontario's Public Health staff will give rescue breaths to family and friends His article: Emergency Medicine News

Abstract:

I read with grave concern the article by Leece, et al. about Toronto's opioid overdose prevention program and teaching laypersons the signs of respiratory emergency and training them to give chest compressions only. Omitted from the training literature were the signs of opioid overdose. Those include not being able to wake up the person; slow, erratic, or stopped breathing; deep snoring or gurgling sounds; blue or purple fingernails or lips; limp body; and very small pupils. These signs would indicate a poisoned patient in coma suffering a respiratory emergency. Cardiac arrest is secondary to respiratory arrest and is associated with severe hypoxia. Prognosis is poor. The patient now needs ACLS beyond the scope of laypersons. The authors note that “significant numbers of opioid-related deaths involve polysubstance overdose with cardiotoxic drugs.” The author's 29th reference makes slim mention of cardiotoxic drugs. Stimulants and other toxins may cause a dysrhythmia, and drugs of abuse cause death from acute respiratory failure. Cyanosis can be cardiotoxic, myocardial infarction can be from lack of oxygen in bloodstream, and every tissue and all organs are dying from lack of oxygen. The authors write, “Painful stimulation may be an effective means of increasing respiratory drive.” This needs redress (primum non nocere); the complications of chest compressions are endless. BLS adds oxygen to the bloodstream. I could find no consensus for chest compressions only for respiratory emergencies, including opioid poisoning (overdose).

Charles W Graham

Community College of Aurora, USA

Title: The treatment of co-occurring substance abuse and bipolar disorder in intensive outpatient program environment
Biography:

Charles W Graham has completed his Psy-D from the Chicago School of Professional Psychology and graduate work at The University of North Texas. He is the
Chief Operating Offi cer/Executive Director of CoreVision Network, a premier dual diagnosis treatment organization based in Colorado Springs, CO. He is one of
the leading professionals in the fi eld of recovery and co-occurring disorders. He was the Program Director at Sober Living by the Sea, one of the premier treatment
centers in America, for fi ve years, and for the past fi ve years he has been the Executive and Clinical Director at Behavioral Health Synergy where he has started up
numerous sober living homes, treatment centers and counseling centers. He is currently an Adjunct Professor of Psychology at the Community College of Aurora.

Abstract:

The necessity to accurately screen, assess and diagnose co-occurring substance abuse and bipolar disorder in the treatment center
environment is the foundation upon which all treatment rests. Th e diagnostic criteria updated in the DSM-5 better represents the
spectrum of both disorders. Th is examination of eff ective intensive outpatient treatment as a step down from residential or therapeutic
community treatment and as an initial treatment approach integrates the traditional cognitive behavioral with psychodynamic and
somatic elements. Clients who are able to demonstrate abstract reasoning have been proven to benefi t from dream analysis, active
imagination and shadow work. Th is addresses the foundational underlying need for processing that can only be done aft er the client
is stabilized, behavioral cravings and cues adjusted and cognitive dysfunction treated. Th is presentation will bring evidenced-based
treatment to one of the most diffi cult client populations.

Jacqueline Heron

Toronto Western Hospital, Canada

Title: Why trauma informed counseling is an essential component of women’s addiction treatment?
Biography:

Jacqueline Heron has completed her Master’s degree in Counseling Psychology from the University of Toronto and a Master’s degree in Education from Central
Michigan University. She works at Toronto Western Hospital as an Addiction Clinician and she also has a Psychotherapy practice in Toronto.

Abstract:

Women who are seeking addiction treatment oft en present with complex spectrum of issues, a history of trauma is oft en most
specifi c to these presenting issues. Unfortunately, due to the stigma that is attached to women and addiction, trauma symptoms
are oft en not detected and/or explored when women present for addiction treatment. Failing to address trauma symptoms can have
devastating implications on the eff ectiveness of addiction treatment, which may result poor therapeutic rapport and disengagement
in treatment. Trauma informed care involves specifi c framework which aims to assist service providers to recognize, understand and
respond to the various eff ects of trauma. More importantly, it assist women in identifying trauma symptoms, understanding the role
that trauma has played in their lives and empower them to create physical, psychological and emotional safety (Alameda County
Behavioral Health Care Services 2013). A case presentation will be used to illustrate that utilizing trauma informed principles can
facilitate greater therapeutic rapport between clients and service providers, increase treatment engagement and signifi cantly aff ect
treatment outcome for women seeking addiction treatment. Th e objectives include: Attendees will realize the prevalence and the
impact of trauma on women who use substances; will be able to identify common signs and symptoms of trauma in women who use
substances; will understand the concept of “Trauma Informed Th erapy” and the benefi ts of using this framework with women who
use substances and will learn how to integrate intellectual knowledge into best practice.

  • Science of Drug abuse and Addiction therapy

Session Introduction

Helen Northcott

Choose A Lifestyle, Canada

Title: Mental Health Comes First
Biography:

Helen Northcot has completed her MA from Andrews University in Berrien Springs, Michigan and her PhD from Almeda University. She is the director of Choose A Lifestyle, which is her private practice for Psychotherapy, Addiction Counselling, Anger Mgt and Alcohol Education classes. She is a Registered Psychotherapist with the new College of Registered Psychotherapists of Ontario. She is a Registered Practical Nurse and is registered with the College of Nurses of Ontario. She is a Vegetarian Cooking Instructor and an Ordained Minister. She has published two books and written for newspapers in Canada and Indonesia.

Abstract:

Thinking erroneously can be dangerous to your health. Volunteers of the National Hopeline Network have answered over seven million calls with the highest percentage(60%) of calls being for those in mental health crisis. Health care systems are challenged to do mental health promotion and prevention to lower costs. Screening for mental health and one’s ability to learn could provide the needed information to be proactive towards faster healing times. The ability to make good choices and to reason from cause to effect is important for a healthy mind.

Michael Groat

The Menninger Clinic, USA

Title: Transforming Vicious Cyles into Virtuous Ones: Psychodynamic Perspectives on Treatment of the Addicted Patient
Biography:

Michael Groat, Director of the Division of Adult Services at the Menninger Clinic, is associate professor of Psychiatry & Behavioral Sciences at the Baylor College of Medicine. He received his master’s degree at Miami University, Ohio, and his doctorate in psychology from the State University of New York, Albany. He completed a four-year clinical psychology fellowship in psychodynamic psychotherapy and dynamic family work at the Austen Riggs Center. He is a past fellow of the American Psychoanalytic Association and Anna Freud/Yale Child Study Center research fellowship. He is a current candidate in adult psychoanalysis at the Houston Center for Psychoanalytic Studies..

Abstract:

Individuals troubled by addictive illness present clinicians with serious challenges regarding the experience, understanding and management of dual diagnosis disorders. Among them, the difficult-to-reach patient features prominently. Such individuals can pull clinicians into intense and endless cycles of relapses, impasses and stalemates, and thwarted progress. Not only are clinicians and families left exhausted and frustrated, patients often earn the distinction of being deemed “treatment resistant.” Outside the extremes, there are many subtle but no less powerful risks for the patient and professional engaged in psychotherapy where enactments around addiction (dishonesty hiding, enabling, etc.) can wind their way throughout a treatment and create havoc of their own. Using clinical examples and research findings from work with difficult-to-treat patients, this presentation will discuss multiple issues involving the vagaries of working with such patients within the framework of psychodynamic treatment. The presenter will lead a discussion with the audience encouraging dialogue from everyone’s clinical experience.

Linda Lane Devlin

C.I.P Board Certified Interventionist, Canada

Title: Interventionists Approach to The Right Treatment
Biography:

Linda Devlin I.C.A.D.C. C.I.P Board Certified Interventionist - International Certification & Reciprocity Consotium (IC&RC) CEO Successonlinecoaching, Co Founder Addiction-Fighters.com Linda's work in the Social Services Industry for over two decades and continued onto being one of the top Executive Management Leaders in the Health Care Industry in Canada. Involved in many Provincial and National Strategies in Health Initiatives including the Council on Workplace Health and Wellness in which the building a Psychological Safe Workplace “practical approaches to Success” were implemented and the creation of the New National Standard of Canada for Psychological Health and Safety in the workplace. Linda’s commitment to service provision is to provide creative solutions that are easily accessed for today’s issues. Linda has been Intervening, teaching and coaching adults in a variety of settings including lectures, discussion groups, seminars, classroom teaching, tutoring and one-on-one coaching.

Abstract:

10 Million Americans have a Dual Diagnosis and a disturbing percentage receive no treatment at all, while others receive treatment for only their addiction or mental illness. To be effective, a treatment program for co-occurring disorders should integrate treatment for both. But without an Intervention, many of Dually Diagnosis individuals may never get the help they need. The symptoms can be so disturbing that alcohol or drug abuse may seem like the only way to cope. One of the things that are so difficult to treat is that it is hard to know where certain symptoms are coming from, if a dual diagnosis patient is suffering from depression, there’s no way to initially know whether the drug addiction or the individual’s mental illness is causing the problem. Treating both the mental illness at the same time, all under “one roof”, has been a very successful method of treatment and Interventions can prevent the life-threatening consequences of drug & alcohol abuse.The Intervention Specialist must recognize the boundaries and limitations of one’s own competencies, and not offer services or use techniques outside of these professional competencies. The Intervention Specialist recognizes the effect of physical and mental impairment and make the best suited Treatment options to guide the process. It is also very effective to include case management principles of inclusion with mental health practitioners. When thoughts and perceptions are altered by mental illness, it’s easy to neglect patients own care. Depression can make you feel that your life isn’t worth saving, while anxiety may drive you away from contact with others.

Lisa M Stephenson

Canisius College, USA

Title: The gut-brain axis: The microbiome’s role in brain disorders
Biography:

Lisa M Stephenson has completed her undergraduate degree at the University of Toronto in 2003 and is certifi ed to teach in Ontario and New York State. She
has spent the last 6 years diligently researching and analysing the emerging medical research on autism and related brain disorders. She recently founded the
Autism Revolution for Medical Intervention (ARMI), a nonprofi t, volunteer led organization working towards redefi ning our understanding of autism and related brain
disorders and currently serves as Principal and Executive Director.

Abstract:

The gut–brain axis refers to the biochemical signaling taking place between the gastrointestinal tract (GIT) and the nervous
system, oft en involving the intestinal microbiota (the microbiome), which have been shown to play an important role in healthy
brain function. Antibiotics, antimicrobial cleaning agents, trauma and carcinogenic compounds in our environment, to name a few,
have contributed to the destruction of the mircrobiome and host immunity. In brain disorders such as autism, the environmental
on slaught has eroded the immature gastrointestinal tract and allowed pathogenic organisms like viruses, bacteria, and fungus to
enter the bloodstream, penetrate the blood-brain-barrier (BBB) and eff ectively force a protective neuro-immune shutdown of blood
fl ow to key parts of the brain. Research now shows that disturbances in the microbiome, resulting in gut permeability, is at the
root of rheumatoid arthritis, allergies, asthma, eczema, Crohn’s/colitis, diabetes, cancer and many other chronic conditions. Th is
breakdown in the GIT and the consequential disruption of the BBB is the underlying biological process behind brain disorders such
as autism, ADHD, schizophrenia, Alzheimer’s, Chronic Fatigue Syndrome/Chronic Fatigue Immune Defi ciency Syndrome (CFS/
CFIDS), anxiety, depression, and more.

Norman S Miller1

Health Advocates PLLC, USA

Title: Opioid Medications: Psychiatric Diagnosis
Biography:

Norman S Miller, MD, JD, PLLC, is the Medical Director, Detoxifi cation and Residential Pro-grams, Bear River Health at Walloon Lake, and the President, Health
Advocates PLLC. He is a Psychiatrist in East Lansing, Michigan and is affi liated with multiple hospitals in the area, including Covenant Medical Center and DMC
Detroit Receiving Hospital. He received his medical degree from Howard University College of Medicine and has been in practice for 41 years. He is one of 6
doctors at Covenant Medical Center and one of 26 at DMC Detroit Receiving Hospital who specialize in Psychiatry

Abstract:

The psychiatric symptoms, particularly depression and anxiety, associated with chronic use of opioid medications as a result of
overprescribing are common and debilitating. Opioid medications are classifi ed as depressants and induce serious depression and
anxiety, particularly with chronic and persistent use. Th e Diagnostic and Statistical Manual of Mental Disorders, fi ft h edition (DSM-
5) provides diagnoses for these opioid-induced conditions. Substance-induced disorders, particularly for depression and anxiety,
include intoxication and withdrawal, substance/medication-induced depressive disorder and substance/medication-induced anxiety
disorder. Importantly, DSM-5 criteria indicate that diagnoses for major depressive disorder and anxiety disorder cannot be made if
there is a substance, such as opioid medications, responsible for the condition. Oft en the way to distinguish between a substanceinduced
disorder and an independent major depressive or anxiety disorder is to discontinue the opioid medications. Given that
opioids are not effi cacious for long-term prescribing, discontinuation of the medication is the treatment of choice

Suhera M Aburawi

University of Tripoli, Libya

Title: Effect of ion channel blockers on pharmacological action of paracetamol using albino mice
Biography:

Suhera M Aburawi has completed her PhD at Cairo University (1999), and MPhill at London Hospital Medical College (1984). She has published more than 23
papers in reputed journals, and contributed to more than 24 conference papers. She was invited, by several journals, to review submitted manuscripts. She also
contributed the chapter on Libya in several editions of D’Vanzo, C.E. and Geissler, E.M. (eds.), Cultural Health Assessment, Mosby Inc

Abstract:

Introduction: Paracetamol is one of the most widely used drugs as antipyretic and analgesic for mild to moderate pain. Currently,
paracetamol is the fi rst-line of choice for pain management and antipyresis. Ion channels are involved in many cellular processes;
drugs acting on ion channels have long been used for the treatment of many diseases.
Objective: To evaluate the eff ect of voltage gated ion channel blockers on analgesic activity of Paracetamol.
Material & Methods: Th e central antinociceptive activity was determined by hot plate test and formalin test (Phase I), using male
albino mice. Anti-infl ammatory activity was determined by formalin test (Phase II). Seven groups of mice were used. Group 1:
control group (1% T80); group 2: treated with (200mg/kg) paracetamol; group 3: treated with diff erent ion channel blockers; group 4:
received combined treatment of ion channel blockers and paracetamol; group 5: received standard drugs as Aspirin (200mg/kg) for
formalin test or tramadol (5mg/kg) for hot plate test. Intraperitoneal injection was adopted.
Results: Pain produced by noxious stimuli (heat and formalin) was signifi cantly reduced by acute administration of paracetamol.
Infl ammation pain produced by formalin injection was signifi cantly decreased by acute administration of paracetamol. Nifedipine
has signifi cant decrease in nociceptive pain (hot plate and formalin test, phase I) and infl ammatory pain (formalin test, phase II).
Verapamil did not produce analgesic or anti-infl ammatory eff ects. Phenytoin produced signifi cant decrease in nociceptive pain using
hot plate test and decrease infl ammatory pain in formalin test (Phase II), while phase I is not sensitive for phenytoin. 4-aminopyridine
produces signifi cant decrease in nociceptive and infl ammatory pain. Combined treatment of nifedipine and paracetamol has
antinociceptive and anti-infl ammatory eff ects but less than the additive eff ect. Verapamil administration with paracetamol produces
antinociceptive and anti-infl ammatory activity. Th is eff ect is due to paracetamol only. Administration of combined treatment of
phenytoin and paracetamol has antinociceptive action and anti-infl ammatory eff ect but less than the additive eff ect which may
reach the ceiling.Th e combined treatment of 4-aminopyridine and paracetamol showed antinociceptive action, 4-aminopyridine
potentiates the eff ect of paracetamol; while the anti-infl ammatory action was less than the additive eff ect.
Conclusion: Paracetamol has central analgesic and anti-infl ammatory eff ect. Nifedipine, phenytoin and 4-aminopyridine, each
alone, produce analgesic and anti-infl ammatory action. Verapamil, in the dose used, by its self has neither analgesic nor antiinfl
ammatory eff ect. Paracetamol analgesic action is not aff ected by nifedipine or phenytoin; it may be concluded that the combined
treatment may reach the ceiling eff ect of analgesic action, while analgesic eff ect of paracetamol is potentiated by 4 aminopyridine.
Combined treatment of nifedipine, phenytoin or 4-aminopyridine with paracetamol produce anti-infl ammatory eff ect, which less
than the additive eff ect. Ceiling eff ect of anti-infl ammatory activity may be produced by combined administration of paracetamol and
nifedipine, phenytoin or 4-aminopyridine. Hot plate model is more sensitive to the eff ect of analgesic agent that relieve neuropathic
pain compared to formalin test (phase I).

Linda Lane Devlin

Success on line coaching & Interventions on demand, Canada

Title: Interventionists approach to “the right treatment” for dual diagnosed patients
Biography:

Linda Lane Devlin ICADC is a CIP board certifi ed Interventionist and has international certifi cation & reciprocity consortium (IC&RC). Her work is in the social
services industry for over two decades and continued onto being one of the top Executive Management Leaders in the Health Care Industry in Canada. She is
involved in many provincial and national strategies in health initiatives including the council on workplace health and wellness in which building a Psychological Safe
Workplace “practical approaches to success” were implemented and the creation of the New National Standard of Canada for Psychological Health and Safety in
the workplace. Her commitment to service provision is to provide creative solutions that are easily accessed for today’s issues. She has been intervening, teaching
and coaching adults in a variety of settings including lectures, discussion groups, seminars, classroom teaching, tutoring and one-on-one coaching.

Abstract:

10 million Americans have a dual diagnosis and a disturbing percentage receive no treatment at all, while others receive
treatment for only their addiction or mental illness. To be eff ective, a treatment program for co-occurring disorders should
integrate treatment for both. But without an intervention, many dually diagnosis individuals may never get the help they need.
Th e symptoms can be so disturbing that alcohol or drug abuse may seem like the only way to cope. One of the things that are
so diffi cult to treat is that it is hard to know where certain symptoms are coming from, if a dual diagnosis patient is suff ering
from depression, there’s no way to initially know whether the drug addiction or the individual’s mental illness is causing the
problem. Treating both the mental illness at the same time, all under “one roof ” has been a very successful method of treatment
and interventions can prevent the life-threatening consequences of drug and alcohol abuse. Th e intervention specialist must
recognize the boundaries and limitations of one’s own competencies and not off er services or use techniques outside of these
professional competencies. Th e intervention specialist recognizes the eff ect of physical and mental impairment and makes the
best suited treatment options to guide the process. It is also very eff ective to include case management principles of inclusion
with mental health practitioners. When thoughts and perceptions are altered by mental illness, it’s easy to neglect patients own
care. Depression can make you feel that your life isn’t worth saving, while anxiety may drive you away from contact with others.

  • Symposium

Session Introduction

Rosa Alati

University of Queensland, Australia

Title: Co morbid drug abuse and mental disorders
Biography:

Dr Rosa Alati is a NHMRC Post-doctoral research fellow with a background in alcohol studies and Indigenous health research. During her early research career, she has taught and researched in the field of Indigenous alcohol misuse, and has had considerable experience in working with Australian Indigenous traditional and non traditional people. In 2001, Rosa Alati returned to full-time PhD studies and became associated with the Mater University Study of Pregnancy, a 21 year birth cohort study started in Brisbane (Australia) in 1981. Following completion of her PhD, she was awarded a 4 year NHMRC Post-doctoral Training Fellowship (Public Health) and joined the Longitudinal Study Unit and the Queensland Alcohol and Drug Research and Education Centre (School of Population Health – University of Queensland). Dr Alati’s research interests are in the life course epidemiology of alcohol and other mental health disorders. She has published on the association between alcohol use and mental health status and on the effects of prenatal alcohol and tobacco exposure on adverse outcomes such as asthma, obesity and alcohol disorders.

Abstract:

There is a growing interest in exploring maternal mental health effects of unintended pregnancies carried to term. However, the evidence base from a small number of available studies is characterised by considerable variability, inconsistency and inconclusive findings. We present a systematic review and meta-analysis of all available studies on unintended pregnancy as these are related to maternal depression. Using PRISMA guideline, we systematically reviewed and meta-analysed studies reporting an association between unintended pregnancy and maternal depression from PubMed, EMBASE, PsychINFO and Google Scholar. We used a priori set criteria and included details of quality and magnitude of effect sizes. Sample sizes, adjusted odds ratios and standard errors were extracted. Random effects were used to calculate pooled estimates in Stata 13. Cochran's Q, I2 and meta-bias statistics assessed heterogeneity and publication bias of included studies.

ROLAND WILLIAMS

Free Life Enterprises, USA

Title: Culturally Sensitive Realignment, Re-Entry and Recovery Utilizing Cognitive Behavioral Therapy with Formerly Incarcerated Clients
Biography:

Roland is an interventionist, author, trainer, counselor and consultant specializing in addiction-related issues. He is the President and Founder of Free Life Enterprises an international counseling and consulting firm, he is the Chairman of the Clinical Advisory Board Clinical for Lionrock Recovery. He is the Coordinator of Chemical Dependency Studies at California University, State East Bay. He is the co-founder and former Executive Director of Alta Mira Recovery Programs, in Sausalito, California, as well as co-founder and former Clinical Director of Bayside Marin, in San Rafael, where he designed the initial clinical model for each facility. Roland is the past Director of Clinical Operations for DARA Thailand where he redesigned the clinical treatment model. Roland worked at Good Samaritan Hospital.

Abstract:

This engaging and challenging presentation allows participants to examine the implications both positive and negative of cultural considerations in the recovery and treatment of addiction with fomerly incarcerated clients. We will examine the impact of Cognitive Behavioral Threrapy on achieving positive treatment outcomes and discuss practical applications on CBT in the clinical setting. We will examine how the Recovery movement itself is a culture, complete with rituals, language, bias and prejudices. We will explore the specific challenges members of various cultures experience as they participate in treatment and self help support groups. We will also examine symptoms experienced by formerly incarcerated clients, particularly Post Incarceration Syndome and Institutiionalized Personality Synsdrom. Participants will have an opportunity to identify their own prejudices and bias, and determine how they affect treatment outcomes in the form of counter-transference. Participants will learn specific cross-cultural counseling techniques that will increase their effectiveness and client retention rates. By exploring methods of assisting clients and treatment providers to realign themselves and their practicies we will in turn, discuss how to move past the victimization of oppression and into the Healing of Recovery.